COVID/RSV/FLU A+B

ALLIANCE IS WORKING DILIGENTLY TO MEET YOUR TESTING NEEDS FOR COVID-19. DUE TO INCREASED SPECIMEN VOLUME, OUR CURRENT TURNAROUND TIME FOR RESULTS IS 48-72 HOURS FROM THE RECEIPT OF THE SPECIMEN. YOUR PROVIDER MAY HAVE MISINFORMED YOU ABOUT THESE TURNAROUND TIMES. PLEASE BE ADVISED THAT WE ARE A PRIVATE LABORATORY, INDEPENDENT OF YOUR REFERRING PROVIDER (DOCTOR). PLEASE DIRECT ANY ADDITIONAL QUESTIONS OR CONCERNS TO YOUR REFERRING PROVIDER (DOCTOR). WE URGE YOU TO REFRAIN FROM CALLING THE LABORATORY FOR TEST RESULTS IF IT HAS BEEN LESS THAN 48 HOURS.

Got the Flu?

Our lab now offers a Respiratory Pathogen Panel to keep you Healthy.

What is RPP Testing?

RPP is a qualitative test that will identify DNA from respiratory viruses and bacteria extracted from nasopharyngeal swabs from individuals with clini- cal signs and symptoms of a respiratory tract infection.

This panel employs PCR (polymerase chain reaction) technology which is used to “amplify” small quantities of nucleic acid into detectable levels which leads to accurate results Our office now offers the RPP test for 20 cold viruses and bacteria infections.

RPP Results

This test can prove that a patient actually has a virus and does not need antibiotics, thereby affirming a provider’s decision to avoid drugs that are unnecessary and can have significant side effects.

High Risk Patients

• Children younger than 2 years of age
• Adults 65 years or older
• Pregnant women

Individuals who have the following medical conditions:

  • Weakened Immune System
  • Chronic Heart Disease
  • Lung Disease
  • Kidney Disease
  • Liver Disease
  • Disease (Diabetes)
  • Transplant Patient

Respiratory Pathogen Panel

The RPP Test can pinpoint the Influenza virus and a number of other respiratory viruses and/or Pneumonia bacteria so your physician can treat it swiftly and accurately; therefore, it could reduce its severity and illness timeframe. Treatment protocols for bacterial respiratory pathogens are vastly different than those for viral pathogens so knowing the pathogen is key to proper and effective treatment.
Molecular testing is far superior to the screen testing traditionally used in physicians’ offices.

  • The RPP panel employs PCR or (Polymerase Chain Reaction) to amplify specific nucleic acid sequences with the pathogens genetic make-up.
  • Our limits of detection are far superior to conventional screen methods as we employ PCR technology, allowing us to amplify small quantities of nucleic acid into detectable levels.
  • Typical symptoms can be dry or productive cough, runny nose, lethargy, abnormal sputum, fever, body aches.
  • They may be asymptomatic and growing the infection. Their bodies keep the disease in check, until It can’t anymore and they become sick.

Look Beyond the Flu

Because a large number of pathogens cause respiratory infections, tests that only identify Flu A and B run the risk of missing the real culprit. Many rapid influenza diagnostic tests sacrifice accuracy for speed, with sensitivities ranging from 50-70%.
The Respiratory Panel (RP) provides an accurate, comprehensive alternative to targeted Influenza testing, and will detect a greater number of pathogens no matter the season or time of year.

SARS-CoV-2 RT-PCR

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), closely related to the SARS virus, is the novel coronavirus that causes coronavirus disease 2019 (COVID-19).

PRICING

SARS-CoV-2 RT-PCR U0003  $740.94

SARS-CoV- 2 48hr Resulting   U0005   $75.00

Specimen Collection    G2023   $46.92

Back to top